MAPT and Alzheimer disease: Currently, biomarkers of AD pathology (Aβ1-42/1-40, T-Tau, and p-Tau), cognitive behavioral syndrome (CBS), and positron emission tomography (PET/CT) are the major methods used to diagnose AD.